The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia
Abstract
✓ The known cytoprotective properties of MgSO 4 led the authors to study its effects on infarct size in rats when administered intraarterially before reversible focal ischemia. Following an intracarotid infusion of MgSO 4 in the amount of 30 mg/kg (24 animals), 90 mg/kg (18 animals), or an equal volume of vehicle (23 animals), middle cerebral artery occlusion was produced in rats by means of an intraluminal suture technique. Reperfusion occurred after 1.5 (42 animals) or 2 hours (23 animals) of ischemia. Automated, volumetric measurements of 2′,3′,5′-triphenyl-2H-tetrazolium chloride—stained coronal brain sections demonstrated a statistically significant decrease in infarct size for MgSO 4 treatment groups compared to controls. Cytoprotection was greater in animals subjected to 1.5 hours of ischemia (28.4% reduction in infarct volume, p ≤ 0.001, Student's t-test), than in those having 2 hours of ischemia (19.3% reduction, p < 0.05). Animals given 90 mg/kg MgSO 4 prior to 1.5 hours of ischemia (12 animals) showed a 59.8% reduction in infarct volume compared to controls (11 animals, p < 0.001) and a 43.1% reduction compared to the 30 mg/kg group (11 animals, p < 0.001). Analysis of variance demonstrated the statistically significant effects of MgSO 4 doses on infarct volume across all groups (F = 22.95, p < 0.0001). The neuroprotective effect of intraarterial MgSO 4 in this model is robust, dose dependent, and related to the duration of ischemia. The compound may be valuable for limiting infarction if given intraarterially before induction of reversible ischemia during cerebrovascular surgery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reversible middle cerebral artery occlusion without craniectomy in rats.
Longa, E. Z., Weinstein, P. R., Carlson, S., & Cummins, R. (1989) · Stroke · doi:10.1161/01.str.20.1.84 · Cited by 7,463
Bederson, J. B., Pitts, L. H., Tsuji, M., Nishimura, M. C., Davis, R. L., & Bartkowski, H. (1986) · Stroke · doi:10.1161/01.str.17.3.472 · Cited by 2,681
Viability thresholds and the penumbra of focal ischemia
Hossmann, K. (1994) · Annals of Neurology · doi:10.1002/ana.410360404 · Cited by 1,370
Experimental studies of ischemic brain edema
Koizumi, J.-I., Yoshida, Y., Nakazawa, T., & Ooneda, G. (1986) · Nosotchu · doi:10.3995/jstroke.8.1 · Cited by 996
Cited by
Saris, N.-E. L., Mervaala, E., Karppanen, H., Khawaja, J. A., & Lewenstam, A. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(99)00258-2 · Cited by 1,366
Diringer, M. N., Bleck, T. P., Claude Hemphill, J., Menon, D., Shutter, L., Vespa, P., Bruder, N., Connolly, E. S., Citerio, G., Gress, D., et al. (2011) · Neurocritical Care · doi:10.1007/s12028-011-9605-9 · Cited by 1,121
Neuroprotection for ischemic stroke: Past, present and future
Ginsberg, M. D. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.12.007 · Cited by 779
Magnesium: physiology and pharmacology
Fawcett, W. J., Haxby, E. J., & Male, D. A. (1999) · British Journal of Anaesthesia · doi:10.1093/bja/83.2.302 · Cited by 707
(2004) · The Lancet · doi:10.1016/s0140-6736(04)15490-1 · Cited by 403
Metadata
- Authors
- Marinov, M. B., Harbaugh, K. S., Hoopes, P. J., Pikus, H. J., & Harbaugh, R. E.
- Venue
- Journal of Neurosurgery
- Published
- 1996-07
- Volume
- 85
- Issue
- 1
- Pages
- 117-124
- ISSN
- 0022-3085 (ISSN-L)
- OpenAlex
- W2070023163
- Cited by
- 185
- References
- 4
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. https://app.cochat.ai/papers/10.3171/jns.1996.85.1.0117
- The paper
- Marinov, M. B., Harbaugh, K. S., Hoopes, P. J., Pikus, H. J., & Harbaugh, R. E. (1996). Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. Journal of Neurosurgery. https://doi.org/10.3171/jns.1996.85.1.0117
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.